Akoustis Technologies Inc (AKTS)

$0.04 0.00 (-9.05%)
Market Cap 5.75M
Revenue (ttm) 27.38M
Net Income (ttm) -167.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -613.40%
Debt to Equity Ratio 0.00
Volume 118,703,398
Avg Vol 26,170,799
Day's Range N/A - N/A
Shares Out 154.59M
Stochastic %K 6%
Beta 1.91
Analysts Sell
Price Target $1.00

Company Profile

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a rad...

Industry: Biotechnology
Sector: Healthcare
Phone: 617-461-4023
Address:
17 Drydock Avenue, Suite 17-401, Boston, United States
RadioIsotope25
RadioIsotope25 Mar. 8 at 2:12 AM
Radiopharm Theranostics: Harnessing isotopes & targeting agents to treat tumours - YouTube $RADX $AKTS $CATX $DAWN https://www.youtube.com/watch?v=A0cOYUeqXGg
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 5 at 2:58 PM
$LNTH $CATX $RADX $AKTS It’s either radiopharma stocks or it’s wrong.
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 2:05 PM
$AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 4 at 12:25 AM
Lantheus is on Fire…$LNTH give some of that hot sauce to Radiopharm Theranostics in which Lantheus owns 15%. And we’re on the 3 yard line for confirmatory Phase2b rad101 data. stock went to $24 last on interim phase 2b data in Dec @ 92% meeting its goal. $RADX $AKTS $CATX
0 · Reply
Gator5326
Gator5326 Mar. 3 at 6:44 PM
$AKTS Great presentation. I love being early in a stock.
0 · Reply
Gator5326
Gator5326 Mar. 1 at 6:52 PM
$AKTS Some a holes think this is a RADX thread. 🤦‍♂️
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 28 at 4:39 PM
$RADX Terbium and Lutetium $AKTS $CATX $IMNM https://youtu.be/AOalQM8zfDM
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 26 at 1:08 AM
Ceo of $RADX ran global breast cancer business at $NVS and was chief commercial officer for their radoopharmaceuticals business AAA.. $CATX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 5:39 PM
HER2 can be the next major driver in Radiopharmaceutical’s ahead of PSMA and RAD202 is positioned to take advantage of it. $RADX $AKTS $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 3:32 AM
Radiopharm Theranostics M&A valuation metrics $AKTS $CATX $RADX
0 · Reply
Latest News on AKTS
Aktis Oncology to Present at Upcoming March Investor Conferences

Feb 24, 2026, 4:05 PM EST - 12 days ago

Aktis Oncology to Present at Upcoming March Investor Conferences

Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate

Feb 24, 2026, 8:00 AM EST - 13 days ago

Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jan 13, 2026, 6:30 AM EST - 7 weeks ago

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO

Jan 9, 2026, 10:05 PM EST - 2 months ago

U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

Jan 9, 2026, 12:58 PM EST - 2 months ago

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

LLY

Aktis Oncology prices upsized US IPO at $18 per share

Jan 8, 2026, 9:20 PM EST - 2 months ago

Aktis Oncology prices upsized US IPO at $18 per share

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Jan 8, 2026, 8:48 PM EST - 2 months ago

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

Jan 6, 2026, 11:50 AM EST - 2 months ago

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

Jan 2, 2026, 10:35 PM EST - 2 months ago

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

OXY BTGO EQPT GRAY IBL KLK ATYR

Aktis Oncology files for US IPO as biotech listings rebound

Dec 19, 2025, 5:51 PM EST - 2 months ago

Aktis Oncology files for US IPO as biotech listings rebound

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Dec 19, 2025, 5:51 PM EST - 2 months ago

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Aktis Oncology IPO Registration Document (S-1)

Dec 19, 2025, 4:02 PM EST - 2 months ago

Aktis Oncology IPO Registration Document (S-1)

RadioIsotope25
RadioIsotope25 Mar. 8 at 2:12 AM
Radiopharm Theranostics: Harnessing isotopes & targeting agents to treat tumours - YouTube $RADX $AKTS $CATX $DAWN https://www.youtube.com/watch?v=A0cOYUeqXGg
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 5 at 2:58 PM
$LNTH $CATX $RADX $AKTS It’s either radiopharma stocks or it’s wrong.
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 4 at 2:05 PM
$AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Mar. 4 at 12:25 AM
Lantheus is on Fire…$LNTH give some of that hot sauce to Radiopharm Theranostics in which Lantheus owns 15%. And we’re on the 3 yard line for confirmatory Phase2b rad101 data. stock went to $24 last on interim phase 2b data in Dec @ 92% meeting its goal. $RADX $AKTS $CATX
0 · Reply
Gator5326
Gator5326 Mar. 3 at 6:44 PM
$AKTS Great presentation. I love being early in a stock.
0 · Reply
Gator5326
Gator5326 Mar. 1 at 6:52 PM
$AKTS Some a holes think this is a RADX thread. 🤦‍♂️
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 28 at 4:39 PM
$RADX Terbium and Lutetium $AKTS $CATX $IMNM https://youtu.be/AOalQM8zfDM
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 26 at 1:08 AM
Ceo of $RADX ran global breast cancer business at $NVS and was chief commercial officer for their radoopharmaceuticals business AAA.. $CATX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 5:39 PM
HER2 can be the next major driver in Radiopharmaceutical’s ahead of PSMA and RAD202 is positioned to take advantage of it. $RADX $AKTS $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 25 at 3:32 AM
Radiopharm Theranostics M&A valuation metrics $AKTS $CATX $RADX
0 · Reply
focafoca99
focafoca99 Feb. 24 at 2:45 PM
$AKTS fast track designation, nice news this morning!
0 · Reply
focafoca99
focafoca99 Feb. 24 at 2:24 PM
$AKTS fast track designation, nice news this morning!
0 · Reply
TheTradeXchange
TheTradeXchange Feb. 24 at 1:01 PM
$AKTS - Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 11:09 PM
MD Anderson made radiopharmaceutical B7-H3 starts trial for $RADX and B7-H3 is a compelling niche that Aktis Oncology has in their pipeline too $AKTS $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 23 at 10:39 PM
$RADX First dosing for B7-H3 tons of optionality here for an acquirer it’s a $2 billion dollar a year drug if fda approved for RADX. AKTS has one as well in B7-H3 niche. $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 21 at 10:40 PM
Radiopharm’s imaging molecule hits mark in observational trial for $500 million dollar first of its kind imaging agent- potentially 3rd largest imaging agent in USA- Clinical Trials Arena $RADX $CATX $AKTS $LNTH https://www.clinicaltrialsarena.com/news/radiopharms-imaging-molecule-hits-mark-in-observational-trial/
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 21 at 12:47 PM
$AKTS Current Stock Price: $18.86
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 20 at 2:43 PM
$RADX Aktis = dead money until data up to 12 mos TLX= rebounding now up 14% last night RADX= up in Australia last night 3% and major data catalysts all 2026. Rad101 affirmation data major de-risk and pipe of 3-4 others with data. CaTX= probably worth more if more data keeps falling in their favor $CATX $PSTV $AKTS
0 · Reply
bigboysmanipulate
bigboysmanipulate Feb. 19 at 10:39 PM
$AKTS a friend of a friend of a friend sent me this who is a hacker . How in the hell did he do this?
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 17 at 6:08 PM
$RADX $AKTS $CATX $IMNM
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 16 at 6:17 PM
Theranostics earmarked as “the future” of radiopharmaceuticals - Pharmaceutical Technology $RADX $CATX $AKTS $LLY https://www.pharmaceutical-technology.com/features/theranostic-radiopharmaceuticals-future-of-radiopharma/
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 13 at 3:33 PM
Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CHRS $PYXS https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/
0 · Reply